Study of linaprazan glurate in healthy volunteers
Treatments studied
Part of Digestive system clinical trials.
This study tests a new drug called linaprazan glurate in healthy adults aged 18 to 65. It looks at how the drug moves through your body and if it affects your heart rhythm.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You are in good general health (no major medical conditions).
- Your body mass index (BMI) is between 18.5 and 35.0.
- You and your partner must use effective birth control during the study.
- You do not have a history of acid reflux or GERD.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well and how safely the drug tegoprazan works for people with gastroesophageal reflux disease (GERD). It may help if you have symptoms like heartburn or acid reflux.
This trial tests a new medicine called anaprazole for people with moderate to severe reflux esophagitis (chronic heartburn and damage to the food pipe). It compares anaprazole to a standard treatment to see which works better and is safer.
This study tests how the medication anaprazole sodium is processed in people with specific health conditions (liver problems, kidney problems, or older age) compared to healthy volunteers. It aims to understand the drug's safety and how it moves through the body.
This study tests a new medicine called Ilaprazole 10 mg to see if it can prevent stomach ulcers caused by NSAIDs (pain relievers like ibuprofen). If you take NSAIDs regularly and have a higher risk of ulcers, this trial may help protect your stomach.
This trial tests a new heartburn medicine called vonoprazan (10 mg) compared to a placebo (sugar pill) for people with chronic heartburn but no damage to the esophagus. If you have heartburn at least 4 days a week, you may be able to try this once-daily pill for 24 weeks.
This trial tests if a new stomach acid medicine (Zastaprazan) affects how well clopidogrel works in heart patients who have had a stent placed. It aims to help people who need both clopidogrel and a stomach acid drug after a procedure.
Hear when a new Pharmacokinetics trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.